Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management |
Stages | Seed, Startup, Early Stage |
Investing | United States • Canada • Europe |
Investment Range | $7,500,000 - $47,200,000 |
Assets Under Management | $100,000,000 |
MP Healthcare Venture Management, Inc. (MPH) is the venture capital arm of Mitsubishi Tanabe Pharma Corporation (MTPC) that is based in Boston, Massachusetts. With assets under management of $100 million, MPH specializes in equity investments in the life sciences sector. They focus on innovative companies that are developing novel therapeutics, platform technologies, and vaccines, targeting industries such as Biotech, Medical Devices (& Hospital Services), and Healthcare (& Wellness). As a venture capital firm, they engage in Seed, Startup, and Early-stage investments, with a minimum investment of $7,500,000 and a maximum of $47,200,000. MPH is committed to collaborating with healthcare entrepreneurs to help build the life science companies of tomorrow. By providing financial support and leveraging their extensive network and deep expertise, MPH plays an instrumental role in the success of the companies they invest in. The portfolio companies have praised MPH for being one of the first investment groups to support them, stating that the firm's early support has been transformative and integral to their long-term success. In addition to financial investment, MPH aids in the development of novel technologies and therapeutics by working closely with the teams behind these innovative ventures, such as Ribometrix, F-star, and QurAlis—companies that have acknowledged the pivotal support received from MPH. The investment firm prides itself on being a valuable partner to healthcare entrepreneurs and contributing to the advancement of medical science and patient care.